October 20, 2015
An Indiana federal judge on Monday found that the claims of consumers in two consolidated proposed class actions alleging Eli Lilly & Co. concealed the withdrawal risks of its antidepressant Cymbalta should be severed into separate complaints, saying the claims are too highly individualized to be combined.